Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
The Journal of Biological Chemistry
|
November 5, 1991
Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins
J P Shaw, D E Akiyoshi, D A Arrigo, et al.
Biochemical and Biophysical Research Communications
|
August 30, 1994
A putative sirolimus (rapamycin) effector protein
Y Chen, H Chen, A E Rhoad, et al.
Journal of Hepatology
|
January 1, 1993
Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F
M E Armstrong, P A Giesa, J P Davide, et al.
Vaccine
|
January 1, 1992
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A
E F Ellerbeck, J A Lewis, D Nalin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
The Journal of Biological Chemistry
|
November 5, 1991
Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins
J P Shaw, D E Akiyoshi, D A Arrigo, et al.
Biochemical and Biophysical Research Communications
|
August 30, 1994
A putative sirolimus (rapamycin) effector protein
Y Chen, H Chen, A E Rhoad, et al.
Journal of Hepatology
|
January 1, 1993
Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F
M E Armstrong, P A Giesa, J P Davide, et al.
Vaccine
|
January 1, 1992
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A
E F Ellerbeck, J A Lewis, D Nalin, et al.
Page
of 1